Superfluidity versus localization in bulk 4He at zero temperature

We present a zero-temperature quantum Monte Carlo calculation of liquid $^4$He immersed in an array of confining potentials. These external potentials are centered in the lattice sites of a fcc solid geometry and, by modifying their well depth and range, the system evolves from a liquid phase towards a progressively localized system which mimics a solid phase. The superfluid density decreases with increasing order, reaching a value $\rho_{\rm s}/\rho = 0.079(16)$ when the Lindemann's ratio of the model equals the experimental value for solid $^4$He.Comment: 5 pages,5 figure

Survey of public definitions of the term 'overdiagnosis' in the UK

Objectives: To determine how ‘overdiagnosis’ is currently conceptualised among adults in the United Kingdom (UK) in light of previous research, which has found that the term is difficult for the public to understand and awareness is low. This study aims to add to current debates on healthcare in which overdiagnosis is a prominent issue. Design: An observational, web-based survey was administered by a survey company. Setting: Participants completed the survey at a time and location of their choosing. Participants: 390 consenting UK adults aged 50-70 years. Quota sampling was used to achieve approximately equal numbers in three categories of education. Primary outcome measures: Participants were asked whether they had seen or heard the term ‘overdiagnosis’. If they had, they were then invited to explain in a free text field what they understood it to mean. If they had not previously encountered it, they were invited to say what they thought it meant. Responses were coded and interpreted using content analysis and descriptive statistics. Results: Data from 390 participants were analysed. Almost a third (30.0%) of participants reported having previously encountered the term. However, their responses often indicated that they had no knowledge of its meaning. The most prevalent theme consisted of responses related to the diagnosis itself. Subthemes indicated common misconceptions, including an ‘overly negative or complicated diagnosis’, ‘false positive diagnosis’ or ‘misdiagnosis’. Other recurring themes consisted of responses related to testing (i.e. ‘too many tests’), treatment (e.g. ‘overtreatment’), and patient psychology (e.g. ’overthinking’). Responses categorised as consistent with ‘overdiagnosis’ (defined as detection of a disease that would not cause symptoms or death) were notably rare (n=10; 2.6%). Conclusions: Consistent with previous research, public awareness of ‘overdiagnosis’ in the UK is low and its meaning is often misunderstood or misinterpreted

ESR Study of (C_5H_{12}N)_2CuBr_4

ESR studies at 9.27, 95.4, and 289.7 GHz have been performed on (C$_5$H$_{12}$N)$_2$CuBr$_4$ down to 3.7 K. The 9.27 GHz data were acquired with a single crystal and do not indicate the presence of any structural transitions. The high frequency data were collected with a polycrystalline sample and resolved two absorbances, consistent with two crystallographic orientations of the magnetic sites and with earlier ESR studies performed at 300 K. Below $B_{C1}=6.6$ T, our data confirm the presence of a spin singlet ground state.Comment: 2 pages, 4 figs., submitted 23rd International Conference on Low Temperature Physics (LT-23), Aug. 200

Magnetic Studies of End-Chain Spin Effects in the Haldane Gap Material Ni(C3H10N2)2N3(ClO4)

Electron spin resonance (ESR), at 9, 94, and 190 GHz, and magnetization studies on polycrystalline, powder, and ultrafine powder samples of Ni(C3H10N2)2N3(ClO4) (NINAZ) have revealed several effects arising from the Haldane phase. Using the g value of the end-chain spin $S$ as determined by ESR, our results confirm that the end-chain spins are S=1/2 and show no evidence for S=1 end-chains. In addition, the ESR signals reveal spectral weight consistent with a model describing interactions between the end-chain spins on the shortest chains and between the magnetic excitations on the chains and the end-chain spins.Comment: Paper revised with additional data, to be published in Physical Review

Unraveling the role of ectopic thymic tissue in patients undergoing thymectomy for myasthenia gravis

Extended thymectomy has been considered the goal of surgery for myasthenia gravis (MG) mainly due to the existence of ectopic thymic tissue. Recently, ectopic thymic tissue has attracted increasing attention in patients with MG following thymectomy. However, the specific role of ectopic thymic tissue in patients with MG is still under debate. A systematic search of the literature was performed on PubMed and Medline according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISM) statement. Studies evaluating the rate of ectopic thymic tissue in patients with MG with or without thymoma were included. Extraction was performed for all eligible studies and the rate of ectopic thymic tissue at common locations was calculated. Eighteen out of fifty-nine studies were eligible for inclusion, of which ten studies reported the common locations of ectopic thymic tissue in mediastinal fat. Of these ten studies, the presence of ectopic thymic tissue was investigated in different anatomical locations in 882 patients, of whom, 509 patients (58%) have at least one positive location with the most common ones being anterior mediastinal fat, pericardiophrenic angles, aortopulmonary window, cervical region (pretracheal fat) and lateral to phrenic nerves. On the other hand, nine studies analyzed the influence of the presence of ectopic thymic tissue on the clinical outcomes of MG patients. Of these, six found that the presence of ectopic thymic tissue in MG patients is a significant predictor of poor outcome after thymectomy, however, the other three did not find a significance. Altogether, ectopic thymic tissue is likely to present in more than a half of patients undergoing thymectomy for MG. Besides, MG patients who have ectopic thymic tissue after thymectomy do not seem to have as good outcome as those who have not

Closed-system behaviour of the Re-Os isotope system recorded in primary and secondary platinum-group mineral assemblages : evidence from a mantle chromitite at Harold's Grave (Shetland ophiolite complex, Scotland)

This study evaluates in detail the mineral chemistry, wholerock and mineral separate Os-isotope compositions of distinct platinumgroup mineral (PGM) assemblages in an isolated chromitite pod at Harold's Grave which occurs in mantle tectonite in the Shetland Ophiolite Complex (SOC), Scotland. This was the first ophiolite sequence worldwide that was shown to contain ppm levels of all six platinum-group elements (PGE) in podiform chromitite, including the contrasting type localities found here and at Cliff. At Harold's Grave the primary PGM assemblage is composed mainly of laurite and/or Os-rich iridium and formed early together with chromite, whereas the secondary PGM assemblage dominated by laurite, Osrich laurite, irarsite, native osmium and Ru-bearing pentlandite is likely to reflect processes including in-situ serpentinization, alteration during emplacement and regional greenschist metamorphism. The osmium isotope data define a restricted range of 'unradiogenic' 187Os/188Os values for coexisting laurite and Os-rich alloy pairs from 'primary' PGM assemblage (0.12473-0.12488) and similar 'unradiogenic' 187Os/188Os values for both 'primary' and 'secondary' PGM assemblages (0.1242±0.0008 and 0.1245±0.0006, respectively), which closely match the bulk 187Os/188Os value of their host chromitite (0.1240±0.0006). The unprecedented isotopic similarity between primary or secondary PGM assemblages and chromitite we report suggests that the osmium isotope budget of chromitite is largely controlled by the contained laurite and Os-rich alloy. This demonstrates that closed system behaviour of the Re- Os isotope system is possible, even during complex postmagmatic hydrothermal and/or metamorphic events. The preserved mantle Os-isotope signatures provide further support for an Enstatite Chondrite Reservoir (ECR) model for the convective upper mantle and are consistent with origin of the complex as a Caledonian ophiolite formed in a suprasubduction zone setting shortly before obduction

Isobaric multiplet mass equation in the A=31A=31 T=3/2T = 3/2 quartets

The observed mass excesses of analog nuclear states with the same mass number $A$ and isospin $T$ can be used to test the isobaric multiplet mass equation (IMME), which has, in most cases, been validated to a high degree of precision. A recent measurement [Kankainen et al., Phys. Rev. C 93 041304(R) (2016)] of the ground-state mass of $^{31}$Cl led to a substantial breakdown of the IMME for the lowest $A = 31, T = 3/2$ quartet. The second-lowest $A = 31, T = 3/2$ quartet is not complete, due to uncertainties associated with the identity of the $^{31}$S member state. Using a fast $^{31}$Cl beam implanted into a plastic scintillator and a high-purity Ge $\gamma$-ray detection array, $\gamma$ rays from the $^{31}$Cl$(\beta\gamma)$$^{31}$S sequence were measured. Shell-model calculations using USDB and the recently-developed USDE interactions were performed for comparison. Isospin mixing between the $^{31}$S isobaric analog state (IAS) at 6279.0(6) keV and a nearby state at 6390.2(7) keV was observed. The second $T = 3/2$ state in $^{31}$S was observed at $E_x = 7050.0(8)$ keV. Isospin mixing in $^{31}$S does not by itself explain the IMME breakdown in the lowest quartet, but it likely points to similar isospin mixing in the mirror nucleus $^{31}$P, which would result in a perturbation of the $^{31}$P IAS energy. USDB and USDE calculations both predict candidate $^{31}$P states responsible for the mixing in the energy region slightly above $E_x = 6400$ keV. The second quartet has been completed thanks to the identification of the second $^{31}$S $T = 3/2$ state, and the IMME is validated in this quartet

Information on 'overdiagnosis' in breast cancer screening on prominent United Kingdom- and Australia-oriented health websites

Objectives: Health-related websites are an important source of information for the public. Increasing public awareness of overdiagnosis and ductal carcinoma in situ (DCIS) in breast cancer screening may facilitate more informed decision-making. This study assessed the extent to which such information was included on prominent health websites oriented towards the general public, and evaluated how it was explained. Design: Cross-sectional study. Setting: Websites identified through Google searches in England (United Kingdom) and New South Wales (Australia) for “breast cancer screening” and further websites included based on our prior knowledge of relevant organisations. Main outcomes: Content analysis was used to determine whether information on overdiagnosis or DCIS existed on each site, how the concepts were described, and what statistics were used to quantify overdiagnosis. Results: After exclusions, ten UK websites and eight Australian websites were considered relevant and evaluated. They originated from charities, health service providers, government agencies, and an independent health organisation. Most contained some information on overdiagnosis (and/or DCIS). Descriptive information was similar across websites. In the UK sample, statistical information was often based on estimates from the Independent UK Panel on Breast Cancer Screening; the most commonly provided statistic was the ratio of breast cancer deaths prevented to overdiagnosed cases (1:3). A range of other statistics was included, such as the yearly number of overdiagnosed cases and the proportion of women screened who would be overdiagnosed. Information on DCIS and statistical information were found less commonly on the Australian websites. Conclusions: Online information about overdiagnosis has become more widely available in 2015-16 compared with the limited accessibility indicated by older research. However, there may be scope to offer more information on DCIS and overdiagnosis statistics on Australian websites. Moreover, the variability in how estimates are presented across UK websites may be confusing for the general public

Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study

Background Uncontrolled studies have shown that short atrioventricular delay dual chamber pacing reduces outflow tract obstruction in hypertrophic obstructive cardiomyopathy. Although the exact mechanism of this beneficial effect is unclear, this seems a promising potential new treatment for hypertrophic obstructive cardiomyopathy. Method In order to evaluate the impact of pacing therapy, we performed a randomized multicentre double-blind crossover (pacemaker activated vs non activated) study to investigate modification of echocardiography, exercise tolerance, angina, dyspnoea and quality of life in 83 patients with a mean age of 53 (range 22-87) years with symptoms refractory or intolerant to classical drug treatment. Results After 12 weeks of activated or inactivated pacing, independent of which phase was first, the pressure gradient fell from 59±36 mmHg to 30±25 mmHg (P<0·001) with active pacing. Exercise tolerance improved by 21% in those patients who at baseline tolerated less than 10 min of Bruce protocol; symptoms of dyspnoea and angina also improved significantly from NYHA class 2·4 to 1·4 and 1·0 to 0·4, respectively (P<0·007). Quality of life assessment with a validated questionnaire objectivated the subjective improvement. Conclusion Pacemaker therapy is of clinical and haemodynamic benefit for patients with hypertrophic obstructive cardiomyopathy, left ventricular outflow gradient at rest over 30 mmHg who are symptomatic despite drug treatmen